# Regeneron Pharmaceuticals, Inc.: filings

REGN · Nasdaq · CIK 872589 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/regn.md) · [Financials](/companies/regn/financials.md) · [Filings](/companies/regn/filings.md) · [Insiders](/companies/regn/insiders.md)

## Reports and events: 327 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 1237, 8-K 210, 144 95, SC 13G/A 72, 10-Q 54, DEFA14A 29, CT ORDER 24, UPLOAD 23, 3 19, 10-K 18, CORRESP 18, DEF 14A 18, SC 13D/A 17, SC 13G 15, 13F-HR 7, 8-K/A 7, ARS 7, 5 6, S-8 6, SC TO-T/A 6, 4/A 5, S-3ASR 5, 424B3 3, 424B5 3, FWP 3, S-8 POS 3, SCHEDULE 13G/A 3, PRE 14A 2, PX14A6G 2, SC 13D 2, SC TO-C 2, SC TO-T 2, 10-K/A 1, N-PX 1, SCHEDULE 13G 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 06:55 ET | [10-Q](/filings/0000872589-26-000034.md) | Quarterly report, period 2026-09-30 | 0000872589-26-000034 |
| 2026-10-30 | 06:50 ET | [8-K](/filings/0000872589-26-000032.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-26-000032 |
| 2026-10-06 | 07:51 ET | [8-K](/filings/0001104659-26-113895.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 8.01 Other events | 0001104659-26-113895 |
| 2026-09-30 | 16:14 ET | [8-K](/filings/0001104659-26-112340.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-26-112340 |
| 2026-07-30 | 06:52 ET | [10-Q](/filings/0000872589-26-000025.md) | Quarterly report, period 2026-06-30 | 0000872589-26-000025 |
| 2026-07-30 | 06:48 ET | [8-K](/filings/0000872589-26-000023.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-26-000023 |
| 2026-07-06 | 07:00 ET | [8-K](/filings/0001104659-26-080562.md) | 2.02 Results of operations | 0001104659-26-080562 |
| 2026-06-17 | 16:05 ET | [8-K](/filings/0001104659-26-075127.md) | 5.07 Shareholder vote results | 0001104659-26-075127 |
| 2026-04-29 | 06:54 ET | [10-Q](/filings/0000872589-26-000016.md) | Quarterly report, period 2026-03-31 | 0000872589-26-000016 |
| 2026-04-29 | 06:50 ET | [8-K](/filings/0000872589-26-000014.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-26-000014 |
| 2026-04-24 | 16:02 ET | [DEF 14A](/filings/0001308179-26-000340.md) | Proxy statement, period 2026-06-12 | 0001308179-26-000340 |
| 2026-04-08 | 07:05 ET | [8-K](/filings/0001104659-26-040661.md) | 2.02 Results of operations | 0001104659-26-040661 |
| 2026-02-04 | 09:08 ET | [10-K](/filings/0000872589-26-000008.md) | Annual report, period 2025-12-31 | 0000872589-26-000008 |
| 2026-01-30 | 06:51 ET | [8-K](/filings/0000872589-26-000004.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-26-000004 |
| 2026-01-12 | 06:48 ET | [8-K](/filings/0001104659-26-002691.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002691 |
| 2025-10-28 | 06:56 ET | [10-Q](/filings/0000872589-25-000028.md) | Quarterly report, period 2025-09-30 | 0000872589-25-000028 |
| 2025-10-28 | 06:50 ET | [8-K](/filings/0000872589-25-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-25-000026 |
| 2025-10-06 | 07:00 ET | [8-K](/filings/0001104659-25-096921.md) | 2.02 Results of operations | 0001104659-25-096921 |
| 2025-08-01 | 06:56 ET | [10-Q](/filings/0000872589-25-000019.md) | Quarterly report, period 2025-06-30 | 0000872589-25-000019 |
| 2025-08-01 | 06:49 ET | [8-K](/filings/0000872589-25-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000872589-25-000017 |
| 2025-06-18 | 16:12 ET | [8-K](/filings/0001104659-25-060637.md) | 5.07 Shareholder vote results | 0001104659-25-060637 |
| 2025-04-29 | 06:51 ET | [10-Q](/filings/0001804220-25-000022.md) | Quarterly report, period 2025-03-31 | 0001804220-25-000022 |
| 2025-04-29 | 06:37 ET | [8-K](/filings/0001804220-25-000020.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-25-000020 |
| 2025-04-29 | 06:03 ET | [DEF 14A](/filings/0001308179-25-000518.md) | Proxy statement, period 2025-06-13 | 0001308179-25-000518 |
| 2025-02-05 | 09:18 ET | [10-K](/filings/0001804220-25-000011.md) | Annual report, period 2024-12-31 | 0001804220-25-000011 |
| 2025-02-04 | 07:11 ET | [8-K](/filings/0001804220-25-000007.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001804220-25-000007 |
| 2025-01-13 | 06:37 ET | [8-K](/filings/0001104659-25-002826.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-002826 |
| 2024-10-31 | 07:16 ET | [10-Q](/filings/0001804220-24-000040.md) | Quarterly report, period 2024-09-30 | 0001804220-24-000040 |
| 2024-10-31 | 07:10 ET | [8-K](/filings/0001804220-24-000038.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-24-000038 |
| 2024-10-07 | 07:00 ET | [8-K](/filings/0001104659-24-106432.md) | 2.02 Results of operations | 0001104659-24-106432 |
| 2024-08-01 | 07:15 ET | [10-Q](/filings/0001804220-24-000028.md) | Quarterly report, period 2024-06-30 | 0001804220-24-000028 |
| 2024-08-01 | 07:06 ET | [8-K](/filings/0001804220-24-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-24-000026 |
| 2024-07-08 | 07:00 ET | [8-K](/filings/0001104659-24-078172.md) | 2.02 Results of operations | 0001104659-24-078172 |
| 2024-06-20 | 16:01 ET | [8-K](/filings/0001104659-24-073372.md) | 5.07 Shareholder vote results | 0001104659-24-073372 |
| 2024-05-02 | 07:13 ET | [10-Q](/filings/0001804220-24-000017.md) | Quarterly report, period 2024-03-31 | 0001804220-24-000017 |
| 2024-05-02 | 07:06 ET | [8-K](/filings/0001804220-24-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-24-000015 |
| 2024-04-25 | 16:01 ET | [DEF 14A](/filings/0001308179-24-000577.md) | Proxy statement, period 2024-06-14 | 0001308179-24-000577 |
| 2024-02-05 | 09:16 ET | [10-K](/filings/0001804220-24-000009.md) | Annual report, period 2023-12-31 | 0001804220-24-000009 |
| 2024-02-02 | 07:16 ET | [8-K](/filings/0001804220-24-000006.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-24-000006 |
| 2024-01-31 | 16:17 ET | [8-K](/filings/0001104659-24-008807.md) | 5.02 Departure or appointment of officers or directors | 0001104659-24-008807 |
| 2024-01-08 | 06:30 ET | [8-K](/filings/0001104659-24-002037.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-002037 |
| 2023-11-02 | 07:22 ET | [10-Q](/filings/0001804220-23-000031.md) | Quarterly report, period 2023-09-30 | 0001804220-23-000031 |
| 2023-11-02 | 07:10 ET | [8-K](/filings/0001804220-23-000029.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-23-000029 |
| 2023-10-05 | 16:04 ET | [8-K](/filings/0001104659-23-107161.md) | 2.02 Results of operations | 0001104659-23-107161 |
| 2023-09-27 | 16:05 ET | [SC 13D/A](/filings/0001104659-23-104277.md) | Ownership report, active investor, amended | 0001104659-23-104277 |
| 2023-09-08 | 17:00 ET | [8-K/A](/filings/0001104659-23-099351.md) | 5.07 Shareholder vote results | 0001104659-23-099351 |
| 2023-09-08 | 16:52 ET | [8-K](/filings/0001104659-23-099345.md) | 5.02 Departure or appointment of officers or directors | 0001104659-23-099345 |
| 2023-08-18 | 17:16 ET | [SC 13D](/filings/0001104659-23-093555.md) | Ownership report, active investor | 0001104659-23-093555 |
| 2023-08-03 | 06:56 ET | [10-Q](/filings/0001804220-23-000023.md) | Quarterly report, period 2023-06-30 | 0001804220-23-000023 |
| 2023-08-03 | 06:48 ET | [8-K](/filings/0001804220-23-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001804220-23-000021 |

Page 1 of 7. [Older](/companies/regn/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 3, 2026, 19:48 ET. No prices; not investment advice.